June 2015

Stem Cells in Drug Discovery 2015, 2-3 June 2015, Cambridge, UK

SELECTBIO is pleased to announce, that due to popular demand we will be hosting a workshop on Stem Cells in Drug Discovery at Buckingham House, Murray Edwards College in Cambridge, UK.

At the workshop you will hear from leaders in stem cell research, working towards models for drug testing; previously thought to be impossible, and professionals screening for efficacy and toxicity of experimental compounds using iPS cell lines, also those responsible for developing the techniques and technologies that are enabling them to do so.

Keynote Speakers:

-          Stephen Minger
Global Director, GE Healthcare

-          Wei Zheng
Group Leader, National Institute of Health

Agenda Topics:

• Cancer Biology and Stem Cell Signalling
• Cardiac iPSCs for Drug Discovery
• Developments from the EBiSC
• Disease Modelling and Phenotypic Drug Screening
• Partnering; Academia, Hospitals and Pharma

The agenda is available to view online.

Stem Cells in Drug Discovery 2015, 2-3 June 2015, Cambridge, UK

SELECTBIO is pleased to announce, that due to popular demand we will be hosting a workshop on Stem Cells in Drug Discovery at Buckingham House, Murray Edwards College in Cambridge, UK.

At the workshop you will hear from leaders in stem cell research, working towards models for drug testing; previously thought to be impossible, and professionals screening for efficacy and toxicity of experimental compounds using iPS cell lines, also those responsible for developing the techniques and technologies that are enabling them to do so.

Keynote Speakers:

-          Stephen Minger
Global Director, GE Healthcare

-          Wei Zheng
Group Leader, National Institute of Health

Agenda Topics:

• Cancer Biology and Stem Cell Signalling
• Cardiac iPSCs for Drug Discovery
• Developments from the EBiSC
• Disease Modelling and Phenotypic Drug Screening
• Partnering; Academia, Hospitals and Pharma

The agenda is available to view online.

Bioheterocycles 2015 on June 7-11, 2015 Metz, France

The XVI conference of this series will gather chemists from over the world, involved in the chemistry of heterocycles. The heterocycles in this case will generally be submitted to biological tests as well in medicine as in agriculture. The scientific programme will include plenary and invited lectures by top chemists in the field and will be completed by oral communications and poster presentations. The conference is intended to synthetic chemists interested in heterocycles and biological activities.

Confirmed speakers

• Prof. Matthias BELLER (UNIVERSITY OF ROSTOCK, Rostock, Germany)
• Prof. Ahcene BOUMENDJEL (UNIVERSITÉ JOSEPH FOURIER, Grenoble, France)
• Prof. Michael GREANEY (THE UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
• Dr Brian JOHNS (GSK, Durham, United States)
• Mrs Esther LETE (UNIVERSIDAD DEL PAÍS VASCO, Bilbao, Spain)
• Prof. Thomas LINDEL (TECHNICAL UNIVERSITY OF BRAUNSCHWEIG, Braunschweig, Germany)
• Prof. Antonello MAI (UNIVERSITA DEGLI STUDI DI ROMA, Roma, Italy)
• Dr Harald WALTER (SYNGENTA CROP PROTECTION MÜNCHWILEN, Stein, Switzerland)

Bioheterocycles 2015 on June 7-11, 2015 Metz, France

The XVI conference of this series will gather chemists from over the world, involved in the chemistry of heterocycles. The heterocycles in this case will generally be submitted to biological tests as well in medicine as in agriculture. The scientific programme will include plenary and invited lectures by top chemists in the field and will be completed by oral communications and poster presentations. The conference is intended to synthetic chemists interested in heterocycles and biological activities.

Confirmed speakers

• Prof. Matthias BELLER (UNIVERSITY OF ROSTOCK, Rostock, Germany)
• Prof. Ahcene BOUMENDJEL (UNIVERSITÉ JOSEPH FOURIER, Grenoble, France)
• Prof. Michael GREANEY (THE UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
• Dr Brian JOHNS (GSK, Durham, United States)
• Mrs Esther LETE (UNIVERSIDAD DEL PAÍS VASCO, Bilbao, Spain)
• Prof. Thomas LINDEL (TECHNICAL UNIVERSITY OF BRAUNSCHWEIG, Braunschweig, Germany)
• Prof. Antonello MAI (UNIVERSITA DEGLI STUDI DI ROMA, Roma, Italy)
• Dr Harald WALTER (SYNGENTA CROP PROTECTION MÜNCHWILEN, Stein, Switzerland)

Bioheterocycles 2015 on June 7-11, 2015 Metz, France

The XVI conference of this series will gather chemists from over the world, involved in the chemistry of heterocycles. The heterocycles in this case will generally be submitted to biological tests as well in medicine as in agriculture. The scientific programme will include plenary and invited lectures by top chemists in the field and will be completed by oral communications and poster presentations. The conference is intended to synthetic chemists interested in heterocycles and biological activities.

Confirmed speakers

• Prof. Matthias BELLER (UNIVERSITY OF ROSTOCK, Rostock, Germany)
• Prof. Ahcene BOUMENDJEL (UNIVERSITÉ JOSEPH FOURIER, Grenoble, France)
• Prof. Michael GREANEY (THE UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
• Dr Brian JOHNS (GSK, Durham, United States)
• Mrs Esther LETE (UNIVERSIDAD DEL PAÍS VASCO, Bilbao, Spain)
• Prof. Thomas LINDEL (TECHNICAL UNIVERSITY OF BRAUNSCHWEIG, Braunschweig, Germany)
• Prof. Antonello MAI (UNIVERSITA DEGLI STUDI DI ROMA, Roma, Italy)
• Dr Harald WALTER (SYNGENTA CROP PROTECTION MÜNCHWILEN, Stein, Switzerland)

2nd NovAliX Conference

Biophysics in Drug Discovery 2015 June 9-12, 2015 Strasbourg, France

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets.

However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of the time, it is the topic of a specialised session within drug discovery conferences, and on the other hand biophysical meetings are often very academy-oriented and rarely extend their scope to drug discovery aspects.

Aiming at filling this gap, the first NovAliX Conference 'Biophysics in Drug Discovery', which was held in October 2013 in Strasbourg, France, was a real success, attracting more than 160 people from 20 countries.

Bringing together the medchem and biophysics communities, the conference, with a 2/1 ratio of participants from industry / academia, was a dense and rich event with lively discussions after presentations, around the posters and during the round table.

The second edition of the conference intends to further develop the synergy between biophysics and medicinal chemistry, which is key to deliver better drugs on a shorter timeline.

Bioheterocycles 2015 on June 7-11, 2015 Metz, France

The XVI conference of this series will gather chemists from over the world, involved in the chemistry of heterocycles. The heterocycles in this case will generally be submitted to biological tests as well in medicine as in agriculture. The scientific programme will include plenary and invited lectures by top chemists in the field and will be completed by oral communications and poster presentations. The conference is intended to synthetic chemists interested in heterocycles and biological activities.

Confirmed speakers

• Prof. Matthias BELLER (UNIVERSITY OF ROSTOCK, Rostock, Germany)
• Prof. Ahcene BOUMENDJEL (UNIVERSITÉ JOSEPH FOURIER, Grenoble, France)
• Prof. Michael GREANEY (THE UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
• Dr Brian JOHNS (GSK, Durham, United States)
• Mrs Esther LETE (UNIVERSIDAD DEL PAÍS VASCO, Bilbao, Spain)
• Prof. Thomas LINDEL (TECHNICAL UNIVERSITY OF BRAUNSCHWEIG, Braunschweig, Germany)
• Prof. Antonello MAI (UNIVERSITA DEGLI STUDI DI ROMA, Roma, Italy)
• Dr Harald WALTER (SYNGENTA CROP PROTECTION MÜNCHWILEN, Stein, Switzerland)

2nd NovAliX Conference

Biophysics in Drug Discovery 2015 June 9-12, 2015 Strasbourg, France

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets.

However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of the time, it is the topic of a specialised session within drug discovery conferences, and on the other hand biophysical meetings are often very academy-oriented and rarely extend their scope to drug discovery aspects.

Aiming at filling this gap, the first NovAliX Conference 'Biophysics in Drug Discovery', which was held in October 2013 in Strasbourg, France, was a real success, attracting more than 160 people from 20 countries.

Bringing together the medchem and biophysics communities, the conference, with a 2/1 ratio of participants from industry / academia, was a dense and rich event with lively discussions after presentations, around the posters and during the round table.

The second edition of the conference intends to further develop the synergy between biophysics and medicinal chemistry, which is key to deliver better drugs on a shorter timeline.

Bioheterocycles 2015 on June 7-11, 2015 Metz, France

The XVI conference of this series will gather chemists from over the world, involved in the chemistry of heterocycles. The heterocycles in this case will generally be submitted to biological tests as well in medicine as in agriculture. The scientific programme will include plenary and invited lectures by top chemists in the field and will be completed by oral communications and poster presentations. The conference is intended to synthetic chemists interested in heterocycles and biological activities.

Confirmed speakers

• Prof. Matthias BELLER (UNIVERSITY OF ROSTOCK, Rostock, Germany)
• Prof. Ahcene BOUMENDJEL (UNIVERSITÉ JOSEPH FOURIER, Grenoble, France)
• Prof. Michael GREANEY (THE UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
• Dr Brian JOHNS (GSK, Durham, United States)
• Mrs Esther LETE (UNIVERSIDAD DEL PAÍS VASCO, Bilbao, Spain)
• Prof. Thomas LINDEL (TECHNICAL UNIVERSITY OF BRAUNSCHWEIG, Braunschweig, Germany)
• Prof. Antonello MAI (UNIVERSITA DEGLI STUDI DI ROMA, Roma, Italy)
• Dr Harald WALTER (SYNGENTA CROP PROTECTION MÜNCHWILEN, Stein, Switzerland)

2nd NovAliX Conference

Biophysics in Drug Discovery 2015 June 9-12, 2015 Strasbourg, France

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets.

However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of the time, it is the topic of a specialised session within drug discovery conferences, and on the other hand biophysical meetings are often very academy-oriented and rarely extend their scope to drug discovery aspects.

Aiming at filling this gap, the first NovAliX Conference 'Biophysics in Drug Discovery', which was held in October 2013 in Strasbourg, France, was a real success, attracting more than 160 people from 20 countries.

Bringing together the medchem and biophysics communities, the conference, with a 2/1 ratio of participants from industry / academia, was a dense and rich event with lively discussions after presentations, around the posters and during the round table.

The second edition of the conference intends to further develop the synergy between biophysics and medicinal chemistry, which is key to deliver better drugs on a shorter timeline.

Molecular Diagnostics Summit June 11-12, 2015 San Diego, CA

• Cancer Marks & Circular Tumor Cells
• Companion Diagnostics
• Pathology Diagnostics
• Point-of-Care Diagnostics

Companion Diagnostics Conference June 11-12, 2015, San Diego, CA

GTCbio invite you to the Companion Diagnostics Conference, which takes place June 11-12, 2015 in San Diego, CA at the Hyatt Regency Mission Bay.

CDx play a significant role in the area of personalized medicine for viral diseases and drug development. There are opportunities and limitations in companion diagnostics and its combination with next generation sequencing towards targeted therapeutic areas. Join fellow researchers to network and discuss these issues and their key findings, including the added value of CDx during drug development and patient management.

Sessions:
I. Biomarkers in Drug Development
II. Implementation of Personalized Medicine
III. CDx: Present and Future
IV. Companion Diagnostics for Cancer and Neurodegenerative Diseases
V. Reimbursement and Clinical Utility

Panel:
I. Market Access for Companion Diagnostics

Point-of-Care Diagnostics Conference June 11-12, 2015, San Diego, CA

GTCbio invite you to attend the Point-of-Care Diagnostics Conference, which will take place on June 11-12, 2015 in San Diego, CA at the Hyatt Regency Mission Bay.

The development of accurate POC testing and its impact on new disease areas and disease management presents many challenges for healthcare providers and manufacturers. Regulatory aspects, validation, clinical applications must be considered when discussing the future of POC. Join academic and industry leaders to discuss these issues, while networking and collaborating on the applications and success rate of POC testing platforms, disease management, and decreasing analytic variability.

Sessions:
I. New and Emerging Technologies
II. New Disease Areas and Global Health
III. Challenges in POC Diagnostics
IV. Integrating POC with Centralized Care
V. Reimbursement and Clinical Utility

Panel:
I. Partnerships: Pharmacies and Manufacturers

2nd NovAliX Conference

Biophysics in Drug Discovery 2015 June 9-12, 2015 Strasbourg, France

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets.

However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of the time, it is the topic of a specialised session within drug discovery conferences, and on the other hand biophysical meetings are often very academy-oriented and rarely extend their scope to drug discovery aspects.

Aiming at filling this gap, the first NovAliX Conference 'Biophysics in Drug Discovery', which was held in October 2013 in Strasbourg, France, was a real success, attracting more than 160 people from 20 countries.

Bringing together the medchem and biophysics communities, the conference, with a 2/1 ratio of participants from industry / academia, was a dense and rich event with lively discussions after presentations, around the posters and during the round table.

The second edition of the conference intends to further develop the synergy between biophysics and medicinal chemistry, which is key to deliver better drugs on a shorter timeline.

Molecular Diagnostics Summit June 11-12, 2015 San Diego, CA

• Cancer Marks & Circular Tumor Cells
• Companion Diagnostics
• Pathology Diagnostics
• Point-of-Care Diagnostics

Companion Diagnostics Conference June 11-12, 2015, San Diego, CA

GTCbio invite you to the Companion Diagnostics Conference, which takes place June 11-12, 2015 in San Diego, CA at the Hyatt Regency Mission Bay.

CDx play a significant role in the area of personalized medicine for viral diseases and drug development. There are opportunities and limitations in companion diagnostics and its combination with next generation sequencing towards targeted therapeutic areas. Join fellow researchers to network and discuss these issues and their key findings, including the added value of CDx during drug development and patient management.

Sessions:
I. Biomarkers in Drug Development
II. Implementation of Personalized Medicine
III. CDx: Present and Future
IV. Companion Diagnostics for Cancer and Neurodegenerative Diseases
V. Reimbursement and Clinical Utility

Panel:
I. Market Access for Companion Diagnostics

Point-of-Care Diagnostics Conference June 11-12, 2015, San Diego, CA

GTCbio invite you to attend the Point-of-Care Diagnostics Conference, which will take place on June 11-12, 2015 in San Diego, CA at the Hyatt Regency Mission Bay.

The development of accurate POC testing and its impact on new disease areas and disease management presents many challenges for healthcare providers and manufacturers. Regulatory aspects, validation, clinical applications must be considered when discussing the future of POC. Join academic and industry leaders to discuss these issues, while networking and collaborating on the applications and success rate of POC testing platforms, disease management, and decreasing analytic variability.

Sessions:
I. New and Emerging Technologies
II. New Disease Areas and Global Health
III. Challenges in POC Diagnostics
IV. Integrating POC with Centralized Care
V. Reimbursement and Clinical Utility

Panel:
I. Partnerships: Pharmacies and Manufacturers

International Conference on Geology on June 22-23, 2015 Florida USA

OMICS Group warmly welcomes you to the International Conference on Geology along with the external scientific association with the researches around the globe, scheduled on June 22-23, 2015 at Florida, USA.

Geology-2015 will place a platform where renowned speakers and scientists across the globe will present their knowledge which will be helpful for the young researchers. The important features of this conference are well organized workshops, events and symposia, Poster presentations and world class exhibits, Panel discussions & interactive sessions, Collaborative Research opportunities.

Geology 2015 aims to accelerate the major disciplines and scientific discoveries in the field of Geology. The central goal of this conference is to advance and accelerate scientific research and discoveries in the fields of Geology and Geoscience. This conference will bring University Professors; research Scientists and Students, Eminent Persons of different Geological Association and Societies to disseminate the findings of geological research. It is a Perfect platform for global networking where new ideas and discoveries in the field of geology is its principal objective.

Our meeting emphasis on sharing the global networking in Geological community, it will seek opportunities to engage representatives of industry, colleges and universities, and public decision making entities in order to foster financial support for geologic community partnerships which will eventually emphasize how Geoscientific information can prevent or lessen the effect of costly, adverse, land-use activities or reduce devastating consequences of natural disasters.

Geoscientists have made significant contribution in understanding the genesis and spatial distribution of resources of industrial and ore minerals, fossil fuels and groundwater. Based on this knowledge several geological, geochemical and geophysical exploration methods have been developed and these are successfully practiced for discovery of earth resources.

Biobanking on June 22-23 2015, London, United Kingdom

The increasing amount of sample and information sharing between biobanks and research facilities has ignited major discussions on how to successfully grow and maintain biobanks. With talks surrounding effective practices required for the management of specimen collections and repositories to ensure preservation of the integrity and future value of specimens, as well as practical implementation issues relating to privacy and confidentiality of research participants, this is a crucial time for the industry.

SMI are proud to present the 5th annual Biobanking Conference, 22nd – 23rd June 2015, London. Through a series of interactive presentations, panel discussions and roundtables, this meeting will feature innovative discussions on relevant and critical issues on how to improve biobanking practices.

With a comprehensive overview of current issues and ongoing considerations in biobanking relevant to both new and seasoned biobank stakeholders, this is a must attend event.

Key topics will include:
 
• How to improve sample management and utilisation
• Biobank interoperability with EU initiatives focusing on the harmonisation of quality standards and data
• Introducing robust strategies to overcome challenges in terms of storage and governance of samples
• Understanding why quality management is essential for the consistent and optimal operation of a repository

International Conference on Geology on June 22-23, 2015 Florida USA

OMICS Group warmly welcomes you to the International Conference on Geology along with the external scientific association with the researches around the globe, scheduled on June 22-23, 2015 at Florida, USA.

Geology-2015 will place a platform where renowned speakers and scientists across the globe will present their knowledge which will be helpful for the young researchers. The important features of this conference are well organized workshops, events and symposia, Poster presentations and world class exhibits, Panel discussions & interactive sessions, Collaborative Research opportunities.

Geology 2015 aims to accelerate the major disciplines and scientific discoveries in the field of Geology. The central goal of this conference is to advance and accelerate scientific research and discoveries in the fields of Geology and Geoscience. This conference will bring University Professors; research Scientists and Students, Eminent Persons of different Geological Association and Societies to disseminate the findings of geological research. It is a Perfect platform for global networking where new ideas and discoveries in the field of geology is its principal objective.

Our meeting emphasis on sharing the global networking in Geological community, it will seek opportunities to engage representatives of industry, colleges and universities, and public decision making entities in order to foster financial support for geologic community partnerships which will eventually emphasize how Geoscientific information can prevent or lessen the effect of costly, adverse, land-use activities or reduce devastating consequences of natural disasters.

Geoscientists have made significant contribution in understanding the genesis and spatial distribution of resources of industrial and ore minerals, fossil fuels and groundwater. Based on this knowledge several geological, geochemical and geophysical exploration methods have been developed and these are successfully practiced for discovery of earth resources.

Biobanking on June 22-23 2015, London, United Kingdom

The increasing amount of sample and information sharing between biobanks and research facilities has ignited major discussions on how to successfully grow and maintain biobanks. With talks surrounding effective practices required for the management of specimen collections and repositories to ensure preservation of the integrity and future value of specimens, as well as practical implementation issues relating to privacy and confidentiality of research participants, this is a crucial time for the industry.

SMI are proud to present the 5th annual Biobanking Conference, 22nd – 23rd June 2015, London. Through a series of interactive presentations, panel discussions and roundtables, this meeting will feature innovative discussions on relevant and critical issues on how to improve biobanking practices.

With a comprehensive overview of current issues and ongoing considerations in biobanking relevant to both new and seasoned biobank stakeholders, this is a must attend event.

Key topics will include:
 
• How to improve sample management and utilisation
• Biobank interoperability with EU initiatives focusing on the harmonisation of quality standards and data
• Introducing robust strategies to overcome challenges in terms of storage and governance of samples
• Understanding why quality management is essential for the consistent and optimal operation of a repository

Lyophilisation - Europe on June 29-30 2015, London, United Kingdom

The global market for lyophilisation is projected to be worth $3.26bn in 2015, spurred by the strong growth of new drugs and efforts to increase clinical approval. Lyophilisation is an established method in the formulation of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines.

As under met needs in drug transport and long term storage continues to prevail, robust lyophilisation methods outlined in PAT and QbD principles as well as alternative technologies will continue to experience strong demand.

This conference will focus on the scale- up efforts in the pharmaceutical industry with key topics in:

• PAT
• Quality by Design
• Vaccines
• Biological drugs
• Spray drying
In addition, a panel discussion on both days will focus on sale up and engineering issues, highlight new areas of innovation and debate whether small scale results in the laboratory provide realistic results in commercial scale up.

Lyophilisation - Europe on June 29-30 2015, London, United Kingdom

The global market for lyophilisation is projected to be worth $3.26bn in 2015, spurred by the strong growth of new drugs and efforts to increase clinical approval. Lyophilisation is an established method in the formulation of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines.

As under met needs in drug transport and long term storage continues to prevail, robust lyophilisation methods outlined in PAT and QbD principles as well as alternative technologies will continue to experience strong demand.

This conference will focus on the scale- up efforts in the pharmaceutical industry with key topics in:

• PAT
• Quality by Design
• Vaccines
• Biological drugs
• Spray drying
In addition, a panel discussion on both days will focus on sale up and engineering issues, highlight new areas of innovation and debate whether small scale results in the laboratory provide realistic results in commercial scale up.